ciprofloxacin has been researched along with Aortic Aneurysm, Thoracic in 6 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Aortic Aneurysm, Thoracic: An abnormal balloon- or sac-like dilatation in the wall of the THORACIC AORTA. This proximal descending portion of aorta gives rise to the visceral and the parietal branches above the aortic hiatus at the diaphragm.
Excerpt | Relevance | Reference |
---|---|---|
"Ciprofloxacin increases susceptibility to aortic dissection and rupture in a mouse model of moderate, sporadic AAD." | 7.88 | Effect of Ciprofloxacin on Susceptibility to Aortic Dissection and Rupture in Mice. ( Azares, AR; Coselli, JS; LeMaire, SA; Luo, W; Ren, P; Shen, YH; Wang, Y; Zhang, C; Zhang, L, 2018) |
"Based on 3721 adverse event reports, all three fluoroquinolones are associated with aortic aneurysm, and levofloxacin is associated with aortic dissection." | 3.91 | Assessing fluoroquinolone-associated aortic aneurysm and dissection: Data mining of the public version of the FDA adverse event reporting system. ( Huang, H; Huang, J; Jia, Y; Meng, L; Qiu, F; Sun, S, 2019) |
"Ciprofloxacin increases susceptibility to aortic dissection and rupture in a mouse model of moderate, sporadic AAD." | 3.88 | Effect of Ciprofloxacin on Susceptibility to Aortic Dissection and Rupture in Mice. ( Azares, AR; Coselli, JS; LeMaire, SA; Luo, W; Ren, P; Shen, YH; Wang, Y; Zhang, C; Zhang, L, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Xiang, B | 2 |
Abudupataer, M | 2 |
Liu, G | 2 |
Zhou, X | 2 |
Liu, D | 2 |
Zhu, S | 2 |
Ming, Y | 2 |
Yin, X | 2 |
Yan, S | 2 |
Sun, Y | 2 |
Lai, H | 2 |
Wang, C | 2 |
Li, J | 2 |
Zhu, K | 2 |
LeMaire, SA | 1 |
Zhang, L | 1 |
Luo, W | 1 |
Ren, P | 1 |
Azares, AR | 1 |
Wang, Y | 1 |
Zhang, C | 1 |
Coselli, JS | 1 |
Shen, YH | 1 |
Nagiah, S | 1 |
Badbess, R | 1 |
Meng, L | 1 |
Huang, J | 1 |
Jia, Y | 1 |
Huang, H | 1 |
Qiu, F | 1 |
Sun, S | 1 |
Schoevaerdts, D | 1 |
Hanon, F | 1 |
Vanpee, D | 1 |
Swine, C | 1 |
Glupczynski, Y | 1 |
Vander Borght, T | 1 |
Marchandise, B | 1 |
John, R | 1 |
Korula, RJ | 1 |
Lal, N | 1 |
Shukla, V | 1 |
Lalitha, MK | 1 |
1 review available for ciprofloxacin and Aortic Aneurysm, Thoracic
Article | Year |
---|---|
Salmonellosis complicating aortic aneurysms.
Topics: Aneurysm, Infected; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Ciprofloxacin; Humans; Ma | 1994 |
5 other studies available for ciprofloxacin and Aortic Aneurysm, Thoracic
Article | Year |
---|---|
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm.
Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear | 2023 |
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm.
Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear | 2023 |
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm.
Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear | 2023 |
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm.
Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear | 2023 |
Effect of Ciprofloxacin on Susceptibility to Aortic Dissection and Rupture in Mice.
Topics: Animals; Anti-Bacterial Agents; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Cells | 2018 |
Unexpected source of
Topics: Aged, 80 and over; Aneurysm, Infected; Anti-Bacterial Agents; Aortic Aneurysm, Thoracic; Bacteremia; | 2018 |
Assessing fluoroquinolone-associated aortic aneurysm and dissection: Data mining of the public version of the FDA adverse event reporting system.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aortic Aneurysm, Thoracic; Aortic | 2019 |
Prolonged survival of an elderly woman with Salmonella dublin aortitis and conservative treatment.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Aortic Aneurysm, Thoracic; Aortitis; Ciprofloxacin; | 2003 |